QA: Carisma Therapeutics Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001485003_2023_Carisma_Therapeutics_Inc.pdf

Logs

warning The stock_price does not exist industry.us_generic {}

Graph

Absolute values for 0001485003, Carisma Therapeutics Inc

  xvar xval
0 AssetsCurrent 189,144,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 30,000
4 LiabilitiesCurrent 30,984,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 46,581,502
9 ResearchAndDevelopmentExpense 38,610,750
10 remainder_Expenses -19,370,042
11 remainder_Revenues 106,908,752
12 remainder_NetIncome 1,464,774
13 remainder_ComprehensiveNetIncome -546,000
  yvar yval
0 Assets 189,174,000
1 Liabilities 30,984,000
2 Expenses 65,822,210
3 Revenues 106,908,752
4 StockholdersEquity 158,190,000
5 NetIncome 42,551,316
6 ComprehensiveNetIncome 42,278,316
7 BaseVar 197,449,868
8 EconomicCapitalRatiobeforeLimitedLiability 3.52
9 EconomicCapitalRatio 4.04

Edgar->Model Mapping

Feature Distribution

Change over Time